Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled…

Overview of attention for article published in Journal of Diabetes, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 674)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 9 news stories from 9 outlets.

Bexagliflozin (Brenzavvy) and dapagliflozin (Farxiga) induced similar HbA1c reductions over 24 weeks in a head-to-head in…

Endocrinology > General Endocrinology News and commentary from the endocrinology world by Kristen Monaco, Senior Staff Writer…

-- Research Adds to Evidence Showing BRENZAVVY’s Similarity to Other SGLT2 Inhibitors -- TheracosBio today announced the…

-- Research Adds to Evidence Showing BRENZAVVY’s Similarity to Other SGLT2 Inhibitors -- TheracosBio today announced the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 5 additional news stories.